Artiva Biotherapeutics, Inc. logo ARTV - Artiva Biotherapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 4
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $37.50 DETAILS
HIGH: $40.00
LOW: $35.00
MEDIAN: $37.50
CONSENSUS: $37.50
UPSIDE: 400.67%

Profitability Ratios

Ratio Value
GP Margin 0.0%
EBIT Margin 0.0%
EBITDA Margin 0.0%
Operating Margin 0.0%
Pretax Margin 0.0%
Cont. Ops Margin 0.0%
Net Margin 0.0%
Bottom Line Margin 0.0%

Liquidity Ratios

Ratio Value
Current Ratio 8.61
Quick Ratio 8.61
Solvency Ratio -3.875
Cash Ratio 2.04

Valuation Ratios

Ratio Value
Price/Earnings
-1.25
Peers avg: 7.2
PEG Ratio 0.04
Forward PEG 0.04
Price/Book 0.95
Price/Sales 0.00
Price/FCF -1.32
Price/Op Cash Flow -1.37

Debt Ratios

Ratio Value
Debt/Assets 0.0836
Debt/Equity 0.0995
Debt/Capital 0.0905
Long-Term Debt/Capital 0.0669
Financial Leverage 1.19

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -5.865
Operating Cash Flow/Sales 0.0%
Free Cash Flow/Operating Cash Flow 103.4%

Coverage Ratios

Ratio Value
Debt Service Coverage -26.57
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -25.09
Operating Cash Flow Coverage -7.01
Capital Expenditure Coverage -29.67
Dividend + Capital Expenditure Coverage -29.67

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.00
EPS -3.431
Debt/Share 0.4476
Cash/Share 4.42
Book Value/Share 4.50
Tangible BV/Share 4.50
Equity/Share 4.50
Operating Cash Flow/Share -3.140
Capital Expenditure/Share 0.106
FCF/Share -3.246

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.926
Price/Fair Value 0.95
Debt/Market Cap 0.1043
Effective Tax Rate 0.0%
Enterprise Value Multiple -1.10